Drugs: perceptions of substances, public policies and users
Tendances n° 131, OFDT, 8 p.
Since 1999, the OFDT has been quantifying the opinions and perceptions of the French population on drugs and related public policies through the EROPP survey (Survey on representations, opinions and perceptions regarding psychoactive drugs). For this fifth edition, a sample of 2 001 individuals, representing the French population aged 18 to 75, was selected based on quota sampling. The survey makes it possible to see how opinions are structured around issues in the public debate but also to consider how opinions in France have developed over the last twenty years. For continuity, most of the themes studied in previous surveys have been kept (for example, the perceived dangerousness of different psychoactive substances, the representation of heroin users and opinions on drug legislation). In addition, questions on current topics and new issues have been added.
In 2018, the EROPP survey focused on five psychoactive substances: tobacco, alcohol, cannabis, cocaine and heroin. Tendances No. 131 first discusses drug-related knowledge and how dangerous they are perceived to be. Secondly, it reports on individuals’ adherence to public policies that are currently in force or being discussed in France or in other countries. Finally, a final section summarises cannabis users’ opinions through a classification that groups together individuals with similar views. Where possible, the results are compared with those from previous surveys.
Authors : Stanislas Spilka, Olivier Le Nézet, Eric Janssen, Alex Brissot, Antoine Philippon, Sandra Chyderiotis
Download the PDF file (1,02 Mo)
Drugs in Europe
The European Drug Report 2023: Trends and Developments presents the EMCDDA’s latest analysis of the drug situation in Europe. Focusing on illicit drug use, related harms and drug supply, the report contains a comprehensive set of national data across these themes and key harm-reduction interventions. This report is based on information provided to the EMCDDA by the EU Member States, the candidate country Türkiye, and Norway, in an annual reporting process.
The annual Statistical Bulletin contains the most recent available data on the drug situation in Europe provided by the Member States. These datasets underpin the analysis presented in the European Drug Report. All data may be viewed interactively on screen and downloaded in Excel format.
The European Union and the drug phenomenon
The European Union & the drug phenomenon : Frequently asked questions, joint publication between the EMCDDA and the European Commission, october 2010, 12 p.